Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

2. Duration of Therapy

Continuous, long-term use of topical calcineurin inhibitors should be avoided, and use should be confined only to areas affected by atopic dermatitis. Patients whose symptoms do not resolve following six weeks of calcineurin inhibitor therapy should be re-evaluated by their health care provider to confirm the diagnosis of atopic dermatitis1-3.

Patients with a confirmed diagnosis of atopic dermatitis will require chronic, intermittent therapy for this condition. Patient profiles with either excessive prescriptions for calcineurin inhibitors during a 30-day time period (greater than 1 x 60 g tube) or without a definitive diagnosis of atopic dermatitis while prescribed a topical calcineurin inhibitor during a 90-day time period will be reviewed.